Sitemap

Pages

About Us
Academic Education Form
CA Compliance
Careers
Compliance
Cookie Policy
Government Hospitals
- AquaBeam Robotic System
- Aquablation Therapy
Healthcare Providers
Nevada Consumer Health Data Privacy Notice
Patents
Privacy
Privacy Policy
Procept Biorobotics
Request More Information
Safety Information
Terms Of Use
Trademark Usage Guidelines
Washington Consumer Health Data Privacy Notice

Risk and Safety Information

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation® therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the HYDROS^® Robotic System or the AquaBeam® Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

As with any surgical urologic procedure, potential perioperative risks of the Aquablation procedure include but are not limited to the following, some of which may lead to serious outcomes and may require intervention: Anesthesia risk, Bladder or prostate capsule perforation, Bladder neck contracture, Bleeding or blood in the urine, Bruising, Penile or pelvic pain, Irritative symptoms, which may include dysuria, urgency or frequency, Infection, Transurethral resection (TUR) syndrome, Electric shock/burn, Urethral damage causing false passage or stricture, Rectal incontinence/perforation, Sexual dysfunction, including ejaculatory and erectile dysfunction, Incontinence or overactive bladder, Embolism, Urinary Retention.

Rx Only

Links

About Us
Aquablation Therapy
Careers
Clinical Data
Contact Us
Investors

Follow us on social media

LinkedIn
Facebook
X

© 2026 PROCEPT BioRobotics Corporation. All rights reserved. AQUABLATION, AquaBeam, HYDROS, FirstAssist AI, PROCEPT BioRobotics, and the PROCEPT BioRobotics logo are trademarks and/or registered trademarks of PROCEPT BioRobotics Corporation in the U.S. and other countries and regions. ML0560.B